TP53 and lung cancer: In an orthotopic (K-RasG12D/+p53-/-) mouse model of lung cancer, overexpression of a soluble dominant-negative MMP14 (DN-MMP14) or pharmacological inhibition of MMP14 blocks the invasion of lung cancer cells in collagen I matrix in vitro and reduces tumor incidence.